American Cannabis Company, Inc. carries a market capitalization of 111,481.00, placing it among publicly traded companies globally. Its enterprise value stands at 1.73M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 111,481.00 |
| Enterprise Value | 1.73M |
American Cannabis Company, Inc. currently has 185.80M shares outstanding.
| Shares Outstanding | 185.80M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 0.49, and the price-to-book ratio stands at -0.05.
| PE Ratio | N/A |
| PS Ratio | 0.49 |
| PB Ratio | -0.05 |
| P/TBV Ratio | -0.50 |
| P/FCF Ratio | 3.31 |
| P/OCF Ratio | 3.31 |
On an enterprise value basis, American Cannabis Company, Inc. trades at an EV/EBITDA multiple of 24.76 and an EV/FCF ratio of 5.35.
| EV / Sales | 1.10 |
| EV / EBITDA | 24.76 |
| EV / EBIT | N/A |
| EV / FCF | 5.35 |
American Cannabis Company, Inc. maintains a current ratio of 0.19, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -150.96, indicating conservative leverage, while an interest coverage ratio of -25.94 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.19 |
| Quick Ratio | 0.06 |
| Debt / Equity | -150.96 |
| Debt / EBITDA | -0.41 |
| Interest Coverage | -25.94 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -121.96 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.61 |
American Cannabis Company, Inc.'s stock has declined approximately -64.70588% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | -64.70588% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, American Cannabis Company, Inc. generated 1.57M in revenue and converted that into -4.01M in net income, yielding earnings per share of -0.03. EBITDA reached -2.33M, while operating income came in at -2.64M.
| Revenue | 1.57M |
| Gross Profit | 171,558.00 |
| Operating Income | -2.64M |
| Pretax Income | -4.01M |
| Net Income | -4.01M |
| EBITDA | -2.33M |
| EBIT | -2.64M |
| Earnings Per Share (EPS) | -0.03 |
American Cannabis Company, Inc. holds 2,747.00 in cash and equivalents against 960,024.00 in total debt, resulting in a net debt position of 577,714.00. Total book value stands at -14.51M, with working capital of -1.78M providing operational flexibility.
| Cash & Cash Equivalents | 2,747.00 |
| Total Debt | 960,024.00 |
| Net Debt | 577,714.00 |
| Equity (Book Value) | -14.51M |
| Book Value Per Share | -0.12 |
| Working Capital | -1.78M |
American Cannabis Company, Inc. produced 233,818.00 in operating cash flow over the past twelve months. After subtracting -2.00 in capital expenditures, free cash flow totaled 233,816.00 - equivalent to 0.00 per share.
| Operating Cash Flow | 233,818.00 |
| Capital Expenditures | -2.00 |
| Free Cash Flow | 233,816.00 |
| FCF Per Share | 0.00 |
American Cannabis Company, Inc. operates with a gross margin of 10.94, reflecting its pricing power and cost economics. The operating margin of -168.31 and net profit margin of -255.49 provide insight into operational efficiency.
| Gross Margin | 10.94 |
| Operating Margin | -168.31 |
| Pretax Margin | -255.49 |
| Profit Margin | -255.49 |
| EBITDA Margin | -148.82 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 26.99 |
| FCF Yield | 30.21 |
American Cannabis Company, Inc.'s most recent stock split took place on May 30, 2013 with a 8484:1 split ratio.
| Last Split Date | 5/30/2013 |
| Split Ratio | 8484:1 |
American Cannabis Company, Inc. posts an Altman Z-Score of -24.60, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -24.60 |